Amends the Chicago Laborers Article of the Illinois Pension Code. Provides that the Board of Trustees of the Fund has the power to issue subpoenas to compel the attendance of witnesses to testify before it and to compel the production of documents and records upon any matter concerning the Fund, including, but not limited to, in conjunction with specified matters (instead of the Board having the authority to compel witnesses to testify before it upon any matter concerning the Fund). Provides that the fees of witnesses for attendance and travel shall be the same as the fees of witnesses before the circuit courts of this State and shall be paid by the party seeking the subpoena. Provides that subpoenas issued under the provisions shall be subject to the Code of Civil Procedure. Removes language providing that the Board may allow witness fees not in excess of $6 per day. Effective immediately.
Sponsored bills
Creates the Civil Liability for Doxing Act. Provides that an individual engages in the act of doxing when that individual intentionally publishes another person's personally identifiable information without the consent of the person whose information is published and: (1) the information is published with the intent that it be used to harm or harass the person whose information is published and with knowledge or reckless disregard that the person whose information is published would be reasonably likely to suffer death, bodily injury, or stalking; and (2) the publishing of the information: (i) causes the person whose information is published to suffer significant economic injury or mental anguish or to fear serious bodily injury or death of the person or a family or household member to the person; or (ii) causes the person whose information is published to suffer a substantial life disruption. Allows a person who is aggrieved by a violation of the Act to bring a civil action against the individual who committed the offense to recover damages and obtain any other appropriate relief. Provides that an individual who is found liable under the Act shall be jointly and severally liable with each other individual, if any, who is found liable under the Act for damages arising from the same violation of the Act. Allows a court to issue a temporary restraining order, emergency order of protection, or preliminary or permanent injunction to restrain and prevent the disclosure or continued disclosure of a person's personally identifiable information or sensitive personal information. Allows a civil action to be brought in any county in which an element of the offense occurred, or in which a person resides who is the subject of the personally identifiable information or sensitive personal information published in violation of the Act.
Amends the Uniform Racial Classification Act. Provides that when a State agency is required by law to compile or report statistical data using racial or ethnic classifications, that State agency shall also include people who are Middle Eastern or North African.
Amends the Illinois Housing Development Act. Provides that the Illinois Housing Development Authority (Authority) may develop a program that provides incentives for the development of affordable housing projects that incorporate urban and suburban gardening programs. Provides that under the program, the University of Illinois shall be consulted regarding best practices in urban gardening and farming, including vertical gardening, aquaponics, and community gardening. Provides that an affordable housing project that incorporates an urban or suburban gardening program must provide any land, buildings, or tools necessary to develop and maintain the garden or farm. Provides that under the program, the Authority shall also coordinate and collaborate with the Department of Commerce and Economic Opportunity to create distribution networks that link urban and suburban gardens with local businesses in order to facilitate the sale and distribution of locally-grown agricultural products and food stuffs to consumers residing within the local community. Provides that the Authority and the Department of Commerce and Economic Opportunity may adopt any rules necessary to implement the program. Effective immediately.
Creates the Digital Forgeries Act. Provides that an individual depicted in a digital forgery has a cause of action against any person who, without the consent of the depicted individual, knowingly distributes a digital forgery, creates a digital forgery with intent to distribute, or solicits the creation of a digital forgery with the intent to distribute: (1) in order to harass, extort, threaten, or cause physical, emotional, reputational, or economic harm to an individual falsely depicted; (2) with reckless disregard for whether such a creation, distribution, reproduction, or manipulation will cause physical, emotional, reputational, or economic harm to an individual falsely depicted; or (3) in order to incite violence or interfere with an official proceeding. Allows a prevailing plaintiff to be awarded damages, costs, and additional relief. Allows the court to grant injunctive relief maintaining the confidentiality of a plaintiff using a pseudonym.
Amends provisions of the Lyme Disease Prevention and Protection Act concerning the Lyme Disease Task Force. Provides that one veterinarian appointed to the Task Force by the Director of Public Health must be a practicing Doctor of Veterinary Medicine. Adds one medical entomologist appointed by the Director of Public Health to the Task Force. Requires the Task Force to meet not less than 4 (rather than 2) times each year.
Amends the Life Care Facilities Act. Requires the Department of Public Health to adopt rules meeting specified requirements for providers of at-home continuing care. Tasks the Department with issuing preliminary certificates of registration, certificates of registration, and renewal certificates of registration to providers of at-home continuing care. Requires providers to renew their registrations every 2 years. Allows the Department to deny, suspend, or revoke a preliminary, initial, or renewal certificate of registration for cause. Contains other provisions.
Amends the Overdose Prevention and Harm Reduction Act. Provides that a pharmacist may sell fentanyl test strips over-the-counter to the public to test for the presence of fentanyl, a fentanyl analogue, or a drug adulterant within a controlled substance. Provides that a county health department may distribute fentanyl test strips at the county health department facility for no fee. Amends the Drug Paraphernalia Control Act. Provides that "drug paraphernalia" does not include equipment, products, or materials to analyze or test for the presence of fentanyl, a fentanyl analogue, or a drug adulterant within a controlled substance.
Amends the Community-Law Enforcement and Other First Responder Partnership for Deflection and Substance Use Disorder Treatment Act. Changes the Act name to the Community Partnership for Deflection and Substance Use Disorder Treatment Act. Modifies and adds definitions. Provides that A law enforcement agency, other first responder entity, or local government agency (rather than only a law enforcement agency or other first responder entity) may establish a deflection program in partnership with one or more licensed providers of substance use disorder treatment services and one or more community members or organizations. Provides that a deflection program may involve a pre-arrest diversion response and proactive identification of persons thought likely to have an untreated or undiagnosed mental illness. Provides that a local deflection program shall also include case management and restorative justice aspects. Provides that a deflection program may accept, receive, and disburse, in furtherance of its duties and functions, any funds, grants, and services made available by the State and its agencies, the federal government and its agencies, units of local government, and private or civic sources. Provides that activities eligible for funding under the Act include naloxone and related harm reduction supplies (rather than related supplies) necessary for carrying out overdose prevention and reversal (rather than overdose reversal) for purposes of distribution to program participants or for use by law enforcement, other first responders, or local governmental agencies and wraparound participant funds to be used to incentivize participation and meet participant needs. Provides that the Legislative Reference Bureau shall reassign the Act in the Illinois Compiled Statutes (to reflect the addition of local government agencies to the Act).
Creates the Pharmaceutical and Health Affordability: Restrictions on Manufacturers' Amoral Behavior through Reasonable Oversight Act. Provides that a manufacturer or wholesale drug distributor shall not engage in price gouging in the sale of an essential off-patent or generic drug. Provides that the Director of Healthcare and Family Services or Director of Central Management Services may notify the Attorney General of any increase in the price of any essential off-patent or generic drug under the State’s Medical Assistance Program or a State health plan, respectively, that amounts to price gouging. Provides that whenever the Attorney General has reason to believe that a manufacturer or wholesale drug distributor of an essential off-patent or generic drug has violated the Act, the Attorney General shall send a notice to the manufacturer or wholesale drug distributor requesting a specified statement. Provides that within 45 days after receipt of the request, the manufacturer or wholesale drug distributor shall submit the statement to the Attorney General. Provides that to accomplish the objectives and carry out the duties prescribed in the Act, the Attorney General may issue subpoenas or examine under oath any person to determine whether a manufacturer or wholesale drug distributor has violated the Act. Provides that upon petition of the Attorney General, a circuit court may issue specified orders against violations of the Act. Contains provisions concerning the disclosure of financial information provided by a manufacturer or wholesale drug distributor to the Attorney General. Effective January 1, 2024.